VMI
MYOK

VHCP Management II’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

VHCP Management II’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-265,000
Closed -$11.4M – 23
2017
Q3 		$11.4M Buy
+265,000
New +$8.45M 3.14% 10

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

VHCP Management II's MYOK Position: Q4 2017 in Review

VHCP Management II sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 265,000 shares — an estimated $11.4M sold.

VHCP Management II first reported a position in MYOK in Q3 2017 and held it in 1 quarter. The position peaked at $11.4M in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • VHCP Management II reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • VHCP Management II sold 265,000 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $11.4M.
  • VHCP Management II first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • VHCP Management II's MyoKardia, Inc. Common Stock position peaked at $11.4M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on VHCP Management II's 13F filing for Q4 2017, filed 13 Feb 2018.